Valuation GlaxoSmithKline Pharmaceuticals Limited

Stocks

Market Closed - Bombay S.E. Other stock markets 13:00:51 27/07/2026 +03			5-day change	1st Jan Change
2,550.20 ^INR	+1.47%		+3.88%	+3.21%

05-29	GlaxoSmithKline Pharmaceuticals Limited Announces Resignation of Dr. Simrat Sohal from Compliance Officer and Ceases to Be the Senior Management Personnel, Effective August 5, 2026	CI
05-13	GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	281,714	224,319	329,173	487,432	386,822	432,019	-
Change	-	-20.37%	46.74%	48.08%	-20.64%	11.68%	-
Enterprise Value (EV)	256,351	207,663	329,173	487,432	386,822	432,019	432,019
Change	-	-18.99%	58.51%	48.08%	-20.64%	11.68%	0%
P/E	16.6x	36.7x	55.8x	52.5x	37.3x	37.6x	33.3x
PBR	10.6x	12.9x	18.5x	25x	17.1x	16.5x	13x
PEG	-	-0.6x	-16.49x	0.9x	3.2x	3.4x	2.6x
Capitalization / Revenue	8.59x	6.9x	9.53x	13x	10.1x	10.3x	9.29x
EV / Revenue	0x	0x	0x	0x	0x	10.3x	9.29x
EV / EBITDA	0x	0x	0x	0x	0x	29.6x	26.2x
EV / EBIT	0x	0x	0x	0x	0x	31.4x	27.5x
EV / FCF	0x	0x	0x	0x	0x	37.3x	33.6x
FCF Yield	2.75%	1.96%	1.67%	2.6%	2.19%	2.68%	2.97%
Dividend per Share ²	30	32	32	42	57	29.5	29.5
Rate of return	1.8%	2.42%	1.65%	1.46%	2.5%	1.16%	1.16%
EPS ²	100	36.05	34.83	54.76	61.15	67.9	76.48
Distribution rate	30%	88.8%	91.9%	76.7%	93.2%	43.4%	38.6%
Net sales ¹	32,780	32,517	34,537	37,492	38,217	41,989	46,489
EBITDA ¹	8,273	8,043	9,087	11,774	13,092	14,603	16,493
EBIT ¹	7,592	7,385	8,390	11,106	12,428	13,760	15,728
Net income ¹	16,947	6,107	5,900	9,276	10,360	11,417	12,543
Net Debt	-25,363	-16,656	-	-	-	-	-
Reference price ²	1,662.95	1,324.15	1,943.10	2,877.30	2,283.40	2,550.20	2,550.20
Nbr of stocks (in thousands)	169,406	169,406	169,406	169,406	169,406	169,406	-
Announcement Date	5/16/22 A	5/17/23 A	5/17/24 A	5/13/25 A	5/13/26 A	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED	37.01x	-	-	1.17%	4.42B
ELI LILLY AND COMPANY	35.93x	12.68x	26.75x	0.57%	1,067B
JOHNSON & JOHNSON	28.24x	6.45x	17.87x	2.04%	635B
ABBVIE INC.	32.64x	7.65x	15.73x	2.65%	458B
ROCHE HOLDING AG	19.22x	4.69x	11.59x	2.82%	347B
NOVARTIS AG	21.56x	5.71x	14.24x	2.81%	295B
ASTRAZENECA PLC	21.1x	4.45x	12.31x	1.98%	262B
NOVO NORDISK A/S	14.14x	5.26x	10.84x	3.54%	216B
AMGEN INC.	24.66x	6.48x	11.43x	2.68%	203B
GILEAD SCIENCES, INC.	-46.58x	5.59x	30.88x	2.55%	161B
Average	18.79x	6.55x	16.85x	2.28%	364.79B
Weighted average by Cap.	24.81x	7.95x	18.71x	1.96%